Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Astrocytoma × Evoked Potentials × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 100 Radiotherapy 52 Bevacizumab 28 Carboplatin 26 Carmustine 25 Magnetic Resonance Spectroscopy 23 Filgrastim 20 Surgical Procedures, Operative 18 Irinotecan 17 Radiation 15 Lomustine 14 Vincristine 13 Etoposide 13 Radiotherapy, Intensity-Modulated 11 Procarbazine 11 Peripheral Blood Stem Cell Transplantation 11 O(6)-benzylguanine 11 Specimen Handling 10 Cyclophosphamide 10 sargramostim 9 Erlotinib Hydrochloride 9 Chemotherapy, Adjuvant 9 antineoplaston AS 2-1 8 antineoplaston A10 8 Thiotepa 8 Granulocyte Colony-Stimulating Factor 8 Flucytosine 8 Cisplatin 8 Everolimus 7 vocimagene amiretrorepvec 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06273176 2024-02-22

RECMAP

Erasmus Medical Center

Astrocytoma, Brain Neoplasms, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡